The data generated by Project GENIE is beneficial to a wide range of stakeholders in the cancer research community:
Researchers can access a rich dataset to explore cancer genomics and develop new hypotheses. Clinicians can leverage genomic insights to inform treatment decisions and improve patient outcomes. Pharmaceutical companies can identify new drug targets and biomarkers for clinical trials. Patients can benefit from more personalized and effective cancer therapies.
